During a goniotomy activation procedure, the surgeon uses a specialized device to create a micro-incision in the trabecular meshwork. The device is designed to precisely target the trabecular meshwork and create a controlled incision that allows for improved drainage of fluid from the eye. The procedure is typically performed under gonioscopic visualization, which allows the surgeon to visualize the trabecular meshwork and ensure accurate placement of the incision. Once the incision is made, the fluid in the eye can flow more freely, reducing intraocular pressure and helping to prevent further damage to the optic nerve.
Goniotomy activation has several benefits over traditional goniotomy procedures. Firstly, it is a minimally invasive procedure that requires only a small incision, reducing the risk of complications and promoting faster healing. Secondly, goniotomy activation has been shown to be highly effective in reducing intraocular pressure in patients with glaucoma, with studies demonstrating significant reductions in pressure in the months following the procedure. Additionally, goniotomy activation can be performed in conjunction with other glaucoma treatments, such as medication or laser therapy, to achieve optimal results.
Goniotomy activation is a promising new technology that offers a minimally invasive and effective treatment option for patients with glaucoma. By creating a precise and controlled incision in the trabecular meshwork, goniotomy activation can help to improve the drainage of fluid from the eye and reduce intraocular pressure. With its benefits of minimal invasiveness, high efficacy, and low risk of complications, goniotomy activation has the potential to revolutionize the treatment of glaucoma and help preserve vision for patients with this sight-threatening condition. Further studies are needed to fully evaluate the safety and efficacy of goniotomy activation, but the initial results are encouraging and suggest a bright future for this new technology.